Colonic Neoplasms Clinical Trial
Official title:
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
Verified date | August 2019 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Uptake of colorectal cancer (CRC) screening is suboptimal in the San Francisco Health Network and access to care may be limited so novel models of health care delivery are warranted. The objective of this study is to examine whether a centralized panel management model with mailed fecal immunochemical test (FIT) will be effective at increasing the uptake of CRC screening and could be developed and sustained within the typical parameters of cost-effectiveness and budget impact analyses.
Status | Completed |
Enrollment | 13470 |
Est. completion date | January 1, 2019 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Asymptomatic men and women - 50 to 75 years of age Exclusion Criteria: - Personal history of polyps requiring colonoscopic surveillance - Homeless - Severe co-morbidities limiting life expectancy e.g., advanced stage cancer |
Country | Name | City | State |
---|---|---|---|
United States | University of California, San Francisco-San Francisco General Hospital | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco | San Francisco Department of Public Health, Stanford University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Completion of FIT- one year | The primary outcome is the completion rate for CRC screening one-year after randomization between mailed FIT outreach and usual care. | One year | |
Secondary | Incomplete FIT- 28 days | Of the patients mailed the FIT kit the number of patients that have not completed their FIT. | 28 days | |
Secondary | FIT Positive | Among the patients that have completed the FIT the percentage that had a positive FIT test. | 1 year | |
Secondary | Completed Colonoscopy | Of the patients that had a positive FIT the percentage of patients that received a colonoscopy. | One year | |
Secondary | Colonoscopy Findings | Of the patients that received a colonoscopy what were the findings (rate of any adenoma, advanced neoplasia, and colorectal cancer). | One year | |
Secondary | Cost | How much the program costed to start and the costs throughout program implementation. | Two years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03746353 -
Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer
|
N/A | |
Recruiting |
NCT05809999 -
IBD Neoplasia Surveillance RCT
|
N/A | |
Recruiting |
NCT06041945 -
Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology
|
N/A | |
Not yet recruiting |
NCT02688699 -
Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract
|
Phase 4 | |
Not yet recruiting |
NCT03175146 -
A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely
|
N/A | |
Completed |
NCT02529007 -
Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening
|
N/A | |
Not yet recruiting |
NCT01929499 -
Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer
|
Phase 2 | |
Completed |
NCT01681472 -
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
Completed |
NCT00535652 -
Concentration of Ertapenem in Colorectal Tissue
|
Phase 4 | |
Terminated |
NCT00267787 -
Molecular Genetic and Pathological Studies of Anal Tumors
|
||
Completed |
NCT05498051 -
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.
|
N/A | |
Recruiting |
NCT05068180 -
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
|
Phase 4 | |
Recruiting |
NCT03314896 -
Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial)
|
N/A | |
Not yet recruiting |
NCT02777437 -
Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT02852915 -
Laparoscopic Surgery for T4 Tumor of the Colon Cancer
|
Phase 3 | |
Completed |
NCT00997802 -
Japanese National Computed Tomographic (CT) Colonography Trial
|
N/A | |
Completed |
NCT01056913 -
NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery
|
Phase 4 | |
Completed |
NCT00537901 -
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
|
N/A | |
Completed |
NCT00470782 -
Aerobic Capacity and Body Composition in Colon Cancer Patients
|
N/A |